planning. Rigorous efficacy and effectiveness data would lead to the development of evidence-based clinical practice guidelines for survivorship care planning (the IOM report’s third recommendation), thereby creating standards of care. From such standards, quality indicators related to survivorship care (promulgated in the fourth recommendation of the IOM report) could be identified and validated. This would spawn a field of inquiry related to access to care and disparities for different survivor populations. The fifth recommendation in the IOM report calls for funded demonstration programs to test models of care, and the final recommendation advocates that public as well as private agencies such as insurance plans should increase their support of survivorship research and expand mechanisms for its conduct. This last recommendation is actually the first step in all of this, however, as establishing an evidence base for the creation and implementation of survivorship care plans through the type of research outlined herein is necessary to realize the IOM’s vision in which attention to the transition from cancer survivor to cancer patient is accepted as a routine part of oncology practice.
1. Johnson FE: Overview, in Johnson FE, Virgo KS (eds): Cancer Patient Follow-Up. St. Louis, Mosby, 1997, p. 4.
2. Ganz PA: A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol 23:5458-5460, 2005.
3. Miedema B, MacDonald I, Tatemichi S: Cancer follow-up care. Patients’ perspectives. Can Fam Physician 49:890-895, 2003.